"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...

Apple altered its watches to circumvent an import ban that the US International Trade Commission issued in 2023. An ITC judge agreed with A...

Two months ago, Apple lost a patent case over the technology its smartwatches use to detect people's pulse rate. The company was ordered to...

Apple said on Monday it would pause sales of its Series 9 and Ultra 2 smartwatches in the United States from this week, as it deals with a ...

The ISO 13485 and MDSAP (Medical Device Single Audit Programme) international certifications endorse medical device manufacturers for their...

Citing reports of IPRs hindering timely provisioning of affordable medical products to the patients, they highlighted that certain members ...

Manufactured at Kunigal, Karnataka, these AMGs are made from a patented technology using a quaternary ammonium compound that the company sa...

Startups that are disrupting traditional models or creating new markets say a shift in technologies and the market opportunity in the count...

There are many companies dealing in manufacturing and export of generic pharmaceutical drugs under contract manufacturing arrangement.

His fall detection device -for which he has filed for a patent -comes wrapped in silicone and can be worn around the waist.

The device will help control 'air embolism', a deadly pathological condition caused by gas bubbles in a vascular system that results in a b...

This could also bolster its case in some of the other European jurisdictions where it is defending patent infringement suits from the Germa...

Move follows investigation by Controller General of Patents, HP Kurian, who found ‘irregularity’ related to patent granted to Braun for Saf...

Diagnosis and treatment of diseases may soon become less expensive.

Reduction in prices of costly imported drugs and medical devices such as stents would remain a pipe dream for some more time.

Diagnosis and treatment of diseases, including high-end surgeries, are set to become less expensive soon.

Venture capitalists pumped a record $9.1 billion into privately-held US biotechnology and medical device companies last year, in hopes of m...